Market Size in 2022 | Market Forecast in 2030 | CAGR (in %) | Base Year |
---|---|---|---|
USD 1983.74 Million | USD 4012.83 Million | 9.18% | 2022 |
The global tissue engineered skin substitute market size was worth around USD 1983.74 Million in 2022 and is predicted to grow to around USD 4012.83 Million by 2030 with a compound annual growth rate (CAGR) of roughly 9.18% between 2023 and 2030. The report analyzes the global tissue engineered skin substitute market drivers, restraints/challenges, and the effect they have on the demands during the projection period. In addition, the report explores emerging opportunities in the tissue engineered skin substitute industry.
Tissue engineering is a way for maintaining, improving, and restoring damaged tissues and organs. It utilizes a mixture of active biological molecules, cells, and scaffolds for developing various functional tissues. Such tissue engineering skin substitutes are a replacement for traditional tissue extraction and wound healing methods.
One of the major factors driving the growth of the global tissue engineered skin substitute market is the growing technological advancements in the healthcare sector. Also, the growing prevalence of chronic and acute wounds in patients all across the globe is also fuelling the growth of the global tissue-engineered skin substitute market. Also, the growing incidents of accidents like burns, road accidents, and trauma events all across the globe are likely to augment the growth of the global tissue-engineered skin substitute market significantly during the forecast period.
The significant spike in demand for skin grafts is also fuelling the growth of the market globally. The skin graft is usually done in the treatment procedures of acute wounds. Synthetic and biosynthetic tissue engineered skin substitutes are utilized in the treatment of severe and moderate burns. Biological skin substitutes are utilized during surgical procedures for healing large wounds. The growing awareness regarding such treatment procedures among people all across the globe is also driving the growth of the market globally. Moreover, the growing demand for breast reconstruction is anticipated to boost the growth of the market globally. The growing investment activities for the development of dermo-epidermal and complex skin substitutes are also escalating the growth of the market globally during the forecast period.
The global tissue engineered skin substitute market can be segmented into end-users, application, products, and regions.
By end-user, the market can be segmented into wound care centers, hospitals, and others. The hospital segment accounts for the largest share in the global tissue engineered skin substitute market due to the growing number of surgeries all across the globe. Moreover, the growing cases of venous leg ulcers and diabetic foot ulcers are the key factors driving the growth of the segment vigorously. Also, the growing incidences of surgical wounds owing to a large number of ongoing surgeries across the world are also driving the growth of the segment.
By application, the market can be segmented into chronic and acute wounds. The acute wound segment holds the largest share in the global tissue engineered skin substitute market due to the growing number of surgeries along with a high prevalence of burn injuries. The acute wounds segment can further be bifurcated into burns, injuries, and surgeries & trauma. The chronic wound segment is anticipated to witness huge growth during the forecast period due to its wide applications in the treatment of extreme cases of venous leg ulcers, diabetic foot ulcers, and pressure ulcers. The chronic wound segment can further be bifurcated into venous leg ulcers, pressure ulcers, diabetic foot ulcers, and others.
By product, the market can be segmented into biological, biosynthetic, and synthetic. The biological segment dominates the global tissue engineered skin substitute market due to the growing prevalence of acute wounds all across the globe.
Report Attributes | Report Details |
---|---|
Report Name | Tissue Engineered Skin Substitute Market Research Report |
Market Size in 2022 | USD 1983.74 Million |
Market Forecast in 2030 | USD 4012.83 Million |
Growth Rate | CAGR of 9.18% |
Number of Pages | 214 |
Key Companies Covered | AMARANTUS BIOSCIENCE HOLDINGS INC., Tissue Regenix, Mallinckrodt, ConvaTec Group PLC, BSN medical, BSN medical, Medline Industries Inc, Kerecis, LifeNet Health, MiMedx., Organogenesis Inc, Regenicin., Integra LifeSciences Corporation, Mölnlycke Health Care AB, and Smith & Nephew. |
Segments Covered | By Product, By Application, By End User, And By Region |
Regions Covered | North America, Europe, Asia Pacific (APAC), Latin America, Middle East, and Africa (MEA) |
Base Year | 2022 |
Historical Year | 2017 to 2021 |
Forecast Year | 2023 - 2030 |
Customization Scope | Avail customized purchase options to meet your exact research needs. Request For Customization |
North America accounts for the largest share in the global tissue engineered skin substitute market due to the growing technological advancements in the region. The growing incidences of burn injuries in the region further boost the growth of the regional market.
Asia Pacific is anticipated to witness huge growth during the forecast period due to the presence of prominent market players in the region. Also, the growing efforts from government authorities to boost the healthcare infrastructure in the region further propel the growth of the regional market during the forecast period.
By Product
By Application
By End User
By Region
North America
What Reports Provides
FrequentlyAsked Questions
Tissue engineering is a way for maintaining, improving, and restoring damaged tissues and organs. It utilizes a mixture of active biological molecules, cells, and scaffolds for developing various functional tissues. Such tissue engineering skin substitutes are a replacement for traditional tissue extraction and wound healing methods.
The global tissue engineered skin substitute market size was worth around USD 1983.74 Million in 2022 and is predicted to grow to around USD 4012.83 Million by 2030.
The CAGR value of the tissue engineered skin substitute market is expected to be around 9.18% during 2023-2030.
North America accounts for the largest share in the global tissue engineered skin substitute market due to the growing technological advancements in the region. The growing incidences of burn injuries in the region further boost the growth of the regional market.
The global tissue engineered skin substitute market is led by players like AMARANTUS BIOSCIENCE HOLDINGS INC., Tissue Regenix, Mallinckrodt, ConvaTec Group PLC, BSN medical, BSN medical, Medline Industries Inc, Kerecis, LifeNet Health, MiMedx., Organogenesis Inc, Regenicin., Integra LifeSciences Corporation, Mölnlycke Health Care AB, and Smith & Nephew.
One of the major factors driving the growth of the global tissue-engineered skin substitute market is the growing technological advancements in the healthcare sector. Also, the growing prevalence of chronic and acute wounds in patients all across the globe is also fuelling the growth of the global tissue-engineered skin substitute market.
HappyClients
Zion Market Research
Tel: +1 (302) 444-0166
USA/Canada Toll Free No.+1 (855) 465-4651
3rd Floor,
Mrunal Paradise, Opp Maharaja Hotel,
Pimple Gurav, Pune 411061,
Maharashtra, India
Phone No +91 7768 006 007, +91 7768 006 008
US OFFICE NO +1 (302) 444-0166
US/CAN TOLL FREE +1 (855) 465-4651
Email: sales@zionmarketresearch.com
We have secured system to process your transaction.
Our support available to help you 24 hours a day, five days a week.
Monday - Friday: 9AM - 6PM
Saturday - Sunday: Closed